GlassScriptPhysician profile
Jonathan Beschloss
NPI 1922196617
$3,287.22
in general payments reported to CMS, 2019-2025
22 companies · $402 in 2025
The $402 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $903 · 2020: $360 · 2021: $401 · 2022: $422 · 2023: $312 · 2024: $488 · 2025: $402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,201.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,002.22 | 2019-2025 | |
| Abbvie INC. | $444.22 | 2019-2025 | Skyrizi, Botox |
| Genzyme Corporation | $377.25 | 2021-2025 | |
| Lilly USA, LLC | $246.38 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $238.53 | 2023-2025 | Sotyktu |
| Amgen INC. | $133.20 | 2024-2025 | Otezla, Otezla |
| Leo Pharma INC. | $131.49 | 2021-2025 | Anzupgo |
| Journey Medical Corporation | $95.12 | 2019 | |
| Pfizer INC. | $81.99 | 2022-2024 | |
| Allergan, INC. | $80.15 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $69.44 | 2019-2021 | |
| Galderma Laboratories, L.P. | $61.84 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $56.34 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $51.48 | 2019-2021 | |
| Blueprint Medicines Corporation | $47.27 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $36.58 | 2020-2021 | |
| Dermira, INC. | $33.64 | 2019 | |
| Ucb, INC. | $30.01 | 2021-2023 | Cimzia |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.96 | 2020 | |
| Merck Sharp & Dohme LLC | $19.24 | 2019 | |
| Biofrontera INC. | $17.68 | 2019 | |
| Mission Pharmacal Company | $13.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Beschloss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.